Mucopolysaccharidosis Treatment
Mar 19, 2025
Mucopolysaccharidosis: How the Different Types Affect Patients and Treatment Approaches?
Mucopolysaccharidosis (MPS) is a group of rare genetic disorders affecting roughly 1 in 25,000 births, yet its impact is profound. Caused by enzyme deficiencies, MPS leads to the buildup of complex sugars in cells, resulting in progressive damage to the heart, bones, brain, and other organs. Symptoms can vary widel...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
